The efficacy over time of androgen deprivation therapy with LHRH analogues in patients with local, regionally advanced, and metastatic prostate carcinoma
Description of Research
Hormonal therapy for prostate cancer with luteinizing hormone releasing hormone agonists (LHRH analogues) is a well-known treatment for prostate cancer. This study will look at how long the effect of LHRH analogues lasts by monitoring the testosterone levels in participant's blood.
Study Number
HSR-04-0396
Inclusion/Notes
Men over the age of 40 with a histological diagnosis of prostate cancer.
